RYSTIGGO Receives U.S FDA Approval

The U.S. Food and Drug Administration has approved RYSTIGGO for the treatment of generalised myasthenia gravis in adult patients who have anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positivity, according to UCB...

COSBI Announce Strategic Partnership with InSilicoTrials To transform Drug Development and Regulatory Approval

InSilicoTrials, a top supplier of artificial intelligence (AI) and simulation tools for drug and medical device development, and COSBI, a premier systems biology research centre, have forged a ground-breaking strategic partnership with the aim of...

ClinChoice Join Hands with Anju Software To Simplify the Complexities of Life Science Information Management

Anju Software, a top supplier of life science technologies, stated that TrialMaster and Anju's eClinical Suite will help ClinChoice grow its market share. Through the cooperation, ClinChoice is able to offer a complete line of flexible, affordable...

EGov Foundation & Assam Government Collaborates to Improve Critical Care in the State

Driving change from the ground up, the eGov Foundation today announced the launch of 23 transformative 10BedICU Projects in Assam in the presence of The Hon'ble Chief Minister of Assam, Shri Himanta Biswa Sarma, and the Hon'ble Health Minister, ....

ZAHIL, a subsidiary of Zydus Lifesciences, acquires a stake in Mylab Discovery Solutions

Zydus Lifesciences, a discovery-driven global life sciences company, has acquired a 6.5% stake in Mylab Discovery Solutions from Rising Sun Holdings, an investment company owned by Adar Poonawalla, through its wholly owned subsidiary Zydus Animal...

BioCity Starts Phase 2 trial of ETA receptor antagonist, SC0062 for Chronic Kidney Disease

BioCityBiopharma, a clinical-stage biopharmaceutical company, announced the start of a randomised, placebo-controlled phase 2 clinical trial of SC0062, a novel oral endothelin A (ETA)-receptor selective antagonist, in China (NCT05687890)....

Dr Reddy's Enters the Indian Trade Generics Market

Global pharmaceutical company Dr Reddy's Laboratories Ltd. today announced its entry into the trade generics business in India with the launch of its new dedicated division, "RGenX." Through this, the pharmaceutical company aims to give patients...

Why Ayurvedic and Herbal Brands Should Consider Contract Manufacturing

Contract manufacturing can assist Ayurvedic and Herbal Brands expand their product lines rapidly and in an efficient manner.

Aurobindo Pharma Arm Enters Into Agreement With Medicines Patent Pool To Develop Anti-Cancer Drug

Aurobindo Pharma Arm Enters Into Agreement With Medicines Patent Pool To Develop Anti-Cancer Drug...

Bayer Collaborates with Inselspital Bern on medical imaging platform Calantic Digital Solutions

Through a subscription license agreement of this specialized platform, Inselspital will use digital applications; including artificial intelligence (AI) enabled tools for medical imaging. The platform contains apps that help radiologists and their...

© 2025 India Pharma Outlook. All Rights Reserved.